Le Lézard
Classified in: Health
Subjects: CCA, FVT

UNIVERSAL HEALTH SERVICES, INC. TO PRESENT AT MAY HEALTHCARE CONFERENCES


KING OF PRUSSIA, Pa., April 23, 2024 /PRNewswire/ -- Universal Health Services, Inc. (NYSE: UHS) announced today that Steve Filton, Executive Vice President and Chief Financial Officer will present at the following conferences:

Tuesday, May 14, 2024, at 8:00am (ET) at the 2024 RBC Capital Markets Global Healthcare Conference in New York, New York

Wednesday, May 29, 2024, at 2:20pm (CT)/3:20pm (ET) at the 2024 Leerink Partners Healthcare Crossroads Conference in Austin, Texas

Live audio webcasts of the presentations will be available on the Company's website (www.uhs.com). For those unable to listen to the live webcast, replays of the presentations will be available on the Company's website for 90 days following the conferences.

Universal Health Services, Inc. ("UHS") is one of the nation's largest providers of hospital and healthcare services. Through its subsidiaries, UHS operates acute care hospitals, behavioral health facilities, outpatient facilities and ambulatory care access points located throughout the United States, Puerto Rico and the United Kingdom.

SOURCE Universal Health Services, Inc.


These press releases may also interest you

at 13:15
Neurocrine Biosciences, Inc. , today presented the CAHtalysttm Pediatric Phase 3 clinical study baseline characteristics data for...

at 13:15
Julie Bank, chief people officer at Brighton Health Plan Solutions, has received an OnCon Icon Award for 2024. This award reflects voting by her peers that ranks her among the top 50 human resources professionals working worldwide....

at 12:46
Melmark, a nationally-recognized non-profit human services provider recently held its biennial fundraising gala, The Dream Maker's Ball: Melmark Generations. Over 200 guests gathered at the Crystal Tea Room in Philadelphia on Saturday, April 20th to...

at 12:25
The "Hematology Collaboration and Licensing Deals 2016-2024" report has been added to ResearchAndMarkets.com's offering. Hematology Collaboration and Licensing Deals provides a comprehensive understanding and unprecedented access to the hematology...

at 12:20
Johnson & Johnson announced today results from the open-label, single-arm Phase 2 Apa-RP study evaluating adjuvant treatment with ERLEADA® (apalutamide) and androgen deprivation therapy (ADT) in patients with HRLPC who have undergone...

at 12:15
According to a "highly troubling" new study, the rising number of cancer cases in young people is being attributed to "accelerated aging." Further alarm is being spread by the United Nations, whose health authorities are predicting global cancer...



News published on and distributed by: